Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

2022/11/05 by Ana Alarcon Tomas, Ana Alarcón Tomás, Joshua A. Fein +38 · 2 citations
Engineering · Medicine · #CAR-T cell therapy research #Lymphoma Diagnosis and Treatment #Silicon Carbide Semiconductor Technologies

paper · doi:10.1038/s41375-022-01739-2

openalex publication_date 2022/11/05 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Citations

• Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia

Cited by

• Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL
• Stuck in traffic: CART cells targeting the tumor microenvironment in hematological malignancies, current advances and future perspectives